Invesco »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Invesco

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Invesco from 13F filings

Historical chart of Invesco investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Invesco consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Invesco

Quarter filed Position value Share count Share price at filing
2024-03-31 $44M 47M 0.94
2023-12-31 $47M 48M 0.98
2023-09-30 $44M 48M 0.92

More positions owned by Invesco

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Visa Com Cl A (V)
JPMorgan Chase & Co. (JPM)
UnitedHealth (UNH)
Exxon Mobil Corporation (XOM)
Eli Lilly & Co. (LLY)
Chevron Corporation (CVX)
Wells Fargo & Company (WFC)

View all positions for Invesco

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ubs Global Asset Management Americas
Lazard Asset Management
Calamos Advisors
Invesco
Advent Capital Management
Opti Capital Management
Steelhead Partners
Aequim Alternative Investments
Citadel Advisors
Davidson Kempner Capital Management
Readystate Asset Management
D. E. Shaw & Co
Zazove Associates
Wellington Management Company
State Street Corporation

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1